Market Cap : 275.4 B | Enterprise Value : 282.38 B | PE Ratio : 9.60 | PB Ratio : 3.15 |
---|
NYSE:PFE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:PFE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Pfizer's dividend payout ratio for the months ended in Jun. 2022 was 0.23.
The historical rank and industry rank for Pfizer's Dividend Payout Ratio or its related term are showing as below:
During the past 13 years, the highest Dividend Payout Ratio of Pfizer was 2.13. The lowest was 0.36. And the median was 0.75.
PFE's Dividend Payout Ratio is ranked worse thanAs of today (2022-08-18), the Dividend Yield % of Pfizer is 3.24%.
During the past 13 years, the highest Trailing Annual Dividend Yield of Pfizer was 5.31%. The lowest was 2.62%. And the median was 3.66%.
Pfizer's Dividends per Share for the months ended in Jun. 2022 was $0.40.
During the past 12 months, Pfizer's average Dividends Per Share Growth Rate was 2.60% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 4.70% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 5.50% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 7.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Pfizer was 22.60% per year. The lowest was -14.70% per year. And the median was 10.40% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
The historical data trend for Pfizer's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Pfizer's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Pfizer's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Pfizer's Dividend Payout Ratio falls into.
Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.
Pfizer's Dividend Payout Ratio for the fiscal year that ended in Dec. 2021 is calculated as
Dividend Payout Ratio | = | Dividends per Share (A: Dec. 2021 ) | / | EPS without NRI (A: Dec. 2021 ) |
= | 1.56 | / | 3.93 | |
= | 0.40 |
Pfizer's Dividend Payout Ratio for the quarter that ended in Jun. 2022 is calculated as
Dividend Payout Ratio | = | Dividends per Share (Q: Jun. 2022 ) | / | EPS without NRI (Q: Jun. 2022 ) |
= | 0.4 | / | 1.73 | |
= | 0.23 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thank you for viewing the detailed overview of Pfizer's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Denton David M | officer: Chief Financial Officer & EVP | 1000 LOWE'S BOULEVARD MOORESVILLE NC 28117 |
Pao William | officer: Executive Vice President | C/O CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Mcdermott Michael | officer: Executive Vice President | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET 235 EAST 42ND STREET NY 10017 |
Malik Aamir | officer: Executive Vice President | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Carapezzi William R Jr | officer: Executive Vice President | 600 MOUNTAIN AVENUE MURRAY HILL NJ 07921 |
Sahni Payal | officer: Executive Vice President | ATTN: PFIZER CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 |
Desmond-hellmann Susan | director | 513 PARNASSUS AVENUE S126 SAN FRANCISCO CA 94143 |
Hockfield Susan | director | GENERAL ELECTRIC COMPANY 41 FARNSWORTH STREET BOSTON MA 02210 |
Damico Jennifer B. | officer: SVP & Controller | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Quincey James | director | THE COCA-COLA COMPANY ONE COCA-COLA PLAZA ATLANTA GA 30313 |
Gottlieb Scott | director | MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142 |
Fonseca Lidia | officer: Executive Vice President | 358 SOUTH MAIN STREET BURLINGTON NC 27215 |
Goettler Michael | officer: Group President | 1000 MYLAN BOULEVARD CANONSBURG PA 15317 |
Rogers Dawn | officer: Executive Vice President | 235 EAST 42ND STREET NEW YORK NY 10017 |
Littman Dan R. | director | ATTN: CORPORATE SECRETARY PFIZER INC. 235 E. 42ND ST NEW YORK NY 10017 |
Other Sources
By Zacks 2022-03-28
By Zacks 2022-03-30
By Zacks 2022-03-25
By Zacks 2022-04-01
By tipranks.com 2022-03-25
By Zacks 2022-04-04
By Zacks 2022-04-04
By Fool 2022-04-05
By Zacks 2022-03-23
By Zacks 2022-04-04
By Zacks 2022-03-22
By tipranks.com 2022-03-30
By Fool 2022-04-06